Has Erika McPhee, MD received payments from drug or device companies?

Yes. Drug and device makers reported $185 in general payments to Erika McPhee, MD across 6 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Erika McPhee, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Erika McPhee, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Erika McPhee, MD

Hand Surgery · Reading, MANPI 1881747749

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 6 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Stryker at 32.9% of the total. Reporting peaked in 2019 at $113 and has fallen 62.9% since, to $42 in 2025. That places this record below the midpoint for hand surgery clinicians in MA, where the typical reported total is $1,924.

$185in general payments, 2019–2025

Across 6 payments — averaging $30.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$61
Aroa Biosurgery Incorporated$42
Endo USA, Inc.$30
Avanos Medical$22
Linvatec Corporation$18
Sanofi-aventis U.S. LLC$12

What the payments were for

Food & beverage$185100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	1	$61
Aroa Biosurgery Incorporated	1	$42
Endo USA, Inc.	1	$30
Avanos Medical	1	$22
Linvatec Corporation	1	$18
Sanofi-aventis U.S. LLC	1	$12

How this compares

$185 in reported general payments places this provider in the 20th percentile of 68 hand surgery providers in Massachusetts.

See all hand surgery providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$166,635

Medicare patients

365

Services billed

15,716

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone Hcl	25	$87
Tramadol Hcl	37	$62

Paid to pharmacies, not to this prescriber.